These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit. Ryder RE Diabet Med; 2015 Mar; 32(3):305-13. PubMed ID: 25472014 [TBL] [Abstract][Full Text] [Related]
28. Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting. Piccinni C; Motola D; Marchesini G; Poluzzi E Diabetes Care; 2011 Jun; 34(6):1369-71. PubMed ID: 21515844 [TBL] [Abstract][Full Text] [Related]
29. Observational follow-up of the PROactive study: a 6-year update. Erdmann E; Song E; Spanheimer R; van Troostenburg de Bruyn AR; Perez A Diabetes Obes Metab; 2014 Jan; 16(1):63-74. PubMed ID: 23859428 [TBL] [Abstract][Full Text] [Related]
30. No strong association is found between pioglitazone and bladder cancer. Wise J BMJ; 2015 Jul; 351():h3934. PubMed ID: 26202496 [No Abstract] [Full Text] [Related]
31. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Lewis JD; Ferrara A; Peng T; Hedderson M; Bilker WB; Quesenberry CP; Vaughn DJ; Nessel L; Selby J; Strom BL Diabetes Care; 2011 Apr; 34(4):916-22. PubMed ID: 21447663 [TBL] [Abstract][Full Text] [Related]
32. Association between pioglitazone and urothelial bladder cancer. Barbalat Y; Dombrovskiy VY; Weiss RE Urology; 2012 Jul; 80(1):1-4. PubMed ID: 22626574 [TBL] [Abstract][Full Text] [Related]
33. Pioglitazone and bladder cancer: the pros and cons. Panikar V J Assoc Physicians India; 2012 Jan; 60():72-3. PubMed ID: 22715550 [No Abstract] [Full Text] [Related]
34. Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone. Aschenbrenner DS Am J Nurs; 2017 Apr; 117(4):25. PubMed ID: 28333739 [No Abstract] [Full Text] [Related]
35. Pioglitazone Use and Risk of Bladder Cancer. Davies BJ JAMA; 2015 Dec; 314(23):2568. PubMed ID: 26670977 [No Abstract] [Full Text] [Related]
36. Pioglitazone Use and Risk of Bladder Cancer. Singh S; Suchard MA JAMA; 2015 Dec; 314(23):2567-8. PubMed ID: 26670976 [No Abstract] [Full Text] [Related]
37. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus? Consoli A; Formoso G Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285 [TBL] [Abstract][Full Text] [Related]
38. Pioglitazone Use and Risk of Bladder Cancer--Reply. Ferrara A; Lewis JD; Habel LA JAMA; 2015 Dec; 314(23):2568-9. PubMed ID: 26670978 [No Abstract] [Full Text] [Related]
39. Meta-analysis confirms raised risk of bladder cancer from pioglitazone. Kermode-Scott B BMJ; 2012 Jul; 345():e4541. PubMed ID: 22763399 [No Abstract] [Full Text] [Related]
40. Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities? Tseng CH J Formos Med Assoc; 2012 Mar; 111(3):123-31. PubMed ID: 22423665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]